Markets.com Logo

CURN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    14.8195$
  • Previous Close
    14.695$
  • 52 Week Change
    6.76$
  • Day Range
    0.12$
  • 52 Week High/Low
    13.43$ - 20.19$
  • Dividend Per Share
    --
  • Market cap
    93 626 K$
  • EPS
    0.42
  • Beta
    0.677
  • Volume
    --

About

Curnis, Inc. (CURN.US) is a technology company specializing in the development and manufacturing of microfluidic technologies, primarily for applications in in-vitro diagnostics and cell therapy. Their products focus on enabling precise control and manipulation of fluids at the microscale, facilitating automation and efficiency in biological and medical processes. The company's solutions are designed for use in areas such as point-of-care diagnostics, drug discovery, and cell processing, providing tools and platforms to improve the accuracy and speed of these procedures.

US Jobs Report and Fed Policy Outlook: Market Expectations and Potential Risks

Sophia Claire|--

Central Banks' Gold Rush: Why They're Piling into the Precious Metal

Liam James|--
GME stock is trading down: What is the target price for GME stock in 2025?

GME stock is trading down: What is the target price for GME stock in 2025?

Ghko B|--
RGTI Stock Price Analysis: Why Rigetti (RGTI) Stock Is Trading Higher Today?

RGTI Stock Price Analysis: Why Rigetti (RGTI) Stock Is Trading Higher Today?

Ghko B|--
XRP Price Prediction: Can Ripple (XRP/USD) Reach $4 in 2025?

XRP Price Prediction: Can Ripple (XRP/USD) Reach $4 in 2025?

Ghko B|--

Apple iPhone 17 Price Speculation & New Devices: A Closer Look at Projections

Sophia Claire|--

Goldman Sachs: Gold Could Hit $5,000 if Fed Credibility Falters

Ava Grace|--

Factors

CURN.US stock price is influenced by several factors. Company Performance: Curnis Biotherapeutics' financial health, revenue growth, and profitability significantly affect investor confidence. Positive earnings reports generally boost the stock. Clinical Trial Results: As a biotech company, Curnis's stock is highly sensitive to the outcomes of its clinical trials. Successful results typically lead to price increases. Regulatory Approvals: FDA approvals for Curnis's drugs are major catalysts. Approval signifies market access and revenue potential. Market Sentiment: Overall investor mood toward biotech stocks impacts Curnis. Bullish markets can lift Curnis shares, while bearish sentiment can pressure them. Competition: The competitive landscape in the pharmaceutical industry influences Curnis. The presence of alternative therapies can reduce market share expectations. Partnerships and Acquisitions: Strategic collaborations and potential acquisitions can significantly impact the stock price. Such deals often unlock value. Economic Conditions: General economic health affects investor risk appetite. During recessions, investors may move away from riskier biotech stocks like Curnis. News and Events: Company-specific news, industry conferences, and macroeconomic announcements can all trigger short-term price fluctuations in CURN.US.

People Also Watch

Latest news

Market Overview: Gold Rallies Amid Fed Rate Cut Expectations

Emma Rose|--

US Job Growth Slows, Unemployment Rises: Rate Cut Outlook Intensifies

Noah Lee|--

Global Market Overview: Weak Nonfarm Data, Gold Hits Highs, OPEC+ Considers Output Hike

Emma Rose|--

Latest Education Articles

Indices CFD Trading for beginner: Dow Jones Index, S&P 500, Nasdaq Index

Indices CFD Trading for beginner: Dow Jones Index, S&P 500, Nasdaq Index

Frances Wang|--
SoFi Technologies Inc Stock Is Rising: How to Trade Sofi Stock CFDs?

SoFi Technologies Inc Stock Is Rising: How to Trade Sofi Stock CFDs?

Frances Wang|--
Crypto CFD Trading Benefits and Risks: Ethereum, XRP, Dogecoin

Crypto CFD Trading Benefits and Risks: Ethereum, XRP, Dogecoin

Ghko B|--